• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s R&D focuses on vaccines addressing high unmet medical needs.

  • Valneva covers the full value chain from research to market.

Welcome to Valneva
A fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines.

2017 Valneva Annual Business Report

— 2017 Valneva Annual Business Report


— Stock information


— May 17, 2018
Valneva Reports Strong Q1 Results and Continues to Advance Key R&D Programs

Read more
— Financial Calendar

June 28, 2018
Shareholders Meeting

See all dates


learn more
play video Company Video

– Upcoming conferences

Euronext TECH40 Investor Forum
Frankfurt, DE
May 15, 2018 
Please update your browser...